Duane Morris Class Action Review - 2023 - Report - Page 53
III.
Top Antitrust Class Action Settlements
In 2022, the top ten antitrust class action settlements totaled over $3.7 billion.
1. $2.67 billion – In Re Blue Cross Blue Shield Antitrust Litigation, Case No.
13-CV-20000 (N.D. Ala. Aug. 9, 2022) (preliminary settlement approval granted
in an antitrust class action resolving claims that the health insurance companies
violated the Sherman Antitrust Act by entering into an unlawful agreement to
restrain competition between them in the markets of selling health insurance).
2. $453 million – In Re Glumetza Antitrust Litigation, Case No. 19-CV-5822
(N.D. Cal. Feb. 3, 2022) (final settlement approval granted in an antitrust class
action resolving claims the companies suppressed generic versions of Glumetza
in order to raise the price of the drug).
3. $145 million – In Re Opana ER Antitrust Litigation, Case No. 14-CV-10150
(N.D. Ill. Nov. 3, 2022) (final settlement approval granted in an antitrust action by
a group of drug wholesalers and large retailers over an alleged scheme to delay
generic versions of the painkiller Opana ER).
52
© Duane Morris LLP 2023
Duane Morris Class Action Review – 2023